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Sadie Wickwar1,2, Hayley McBain1,3, Stanton P. Newman1, Shashivadan P. Hirani1, Catherine Hurt1, Nicola Dunlop2,
Chris Flood1 and Daniel G. Ezra2*Erratum
Unfortunately, the original version of this article [1]
contained an error. In the Trial registration section
the Clinicaltrials.ogv ID was included incorrectly as
NCT102577224. The Correct ID is NCT02577224.
There will also be an update to correct this error.
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